Community pharmacy gross margin is set centrally by the Drug Tariff and retrospectively adjusted via Category M clawback. That means your margin is not a number you control at the point of dispensing; it is a number that emerges from the Tariff movement in subsequent months. Margin variance analysis against the Tariff, not year-end bookkeeping, is the core monthly job. Service income under Pharmacy First and similar schemes is a separately accounted, growing revenue line that must be tracked apart from dispensing to see the true picture. Pharmacy income is contract-driven, not till-driven, which is why benchmarking a pharmacy against generic retail metrics is meaningless. We bring the literacy a generalist accountant structurally cannot.
Category M is the mechanism by which NHSBSA retrospectively adjusts Drug Tariff reimbursement prices to reflect actual drug costs to dispensing contractors. The adjustment happens in later periods, not at the time of dispensing. If your monthly accounts do not reconcile the Tariff adjustment to your ledger, the margin leakage is invisible until year-end, by which point the opportunity to act on it has passed.
Pharmacy income is not shop takings. It is reimbursement under the Drug Tariff and remuneration under the CPCF fee schedule, with service income as a further separately tracked line. Applying generic retail gross-margin benchmarks to a dispensing pharmacy produces a comparison that has no diagnostic value. The benchmark that matters is your dispensing margin against the Tariff, your remuneration income against what you are eligible for, and your service income against your capacity.
Pharmacy First and similar advanced services generate income under a separately structured NHS payment mechanism, with their own fee rates and eligibility thresholds. Where this income is absorbed into overall NHS income without separate tracking, the profitability of the service line is invisible and the benchmarking picture is distorted. As service income grows as a share of total pharmacy income, getting the attribution right becomes increasingly important.
Most pharmacy owners who ask 'how am I doing?' get a year-end set of accounts that shows total income and total costs with no margin segmentation and no Tariff-adjusted comparison. That is not a management tool; it is a filing exercise. The monthly job requires accounts that separate dispensing margin, remuneration, and service income, compare each against the relevant benchmark, and flag variances before they compound.
We reconcile your NHS reimbursement receipts to the Tariff each month, track the Category M and price-adjustment impacts, and produce a margin-variance report showing where your dispensing margin is moving and why. Where under-recovery appears, we flag it in the month and advise on whether it reflects a Tariff movement, a submission error, or a NHSBSA reconciliation issue.
We separately account for Pharmacy First and other advanced service income, reconcile payments against your eligible activity, and include the service-income line in monthly management accounts as a distinct, benchmarked revenue stream. As this income line grows, having it clearly separated from dispensing reimbursement is increasingly important for both management decisions and tax accuracy.
We produce monthly management accounts designed for pharmacy operators, segmented by revenue stream (dispensing reimbursement, remuneration, service income, OTC retail) with appropriate benchmarks for each. For multi-store owners, we produce consolidated and store-level views that make like-for-like variance visible. The FP34 cash-flow estimator on our reconciliation service page can also model the working-capital dimension alongside the margin analysis.
Tell us about your situation and we will reply within 24 hours.